Taussig–Bing syndrome
| Taussig–Bing syndrome | |
|---|---|
| Synonyms | Double outlet right ventricle with subpulmonary ventricular septal defect |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Cyanosis, heart murmur, congestive heart failure |
| Complications | Pulmonary hypertension, heart failure |
| Onset | Neonatal |
| Duration | Lifelong |
| Types | N/A |
| Causes | Congenital heart defect |
| Risks | Genetic predisposition, maternal diabetes |
| Diagnosis | Echocardiography, cardiac MRI, cardiac catheterization |
| Differential diagnosis | Tetralogy of Fallot, Transposition of the great arteries |
| Prevention | N/A |
| Treatment | Surgical repair, medication |
| Medication | Diuretics, ACE inhibitors, beta blockers |
| Prognosis | Variable, depends on surgical outcome |
| Frequency | Rare |
| Deaths | N/A |
Taussig–Bing Syndrome
Taussig–Bing syndrome is a rare congenital heart defect characterized by a combination of transposition of the great arteries (TGA) and a ventricular septal defect (VSD). This condition is named after the cardiologists Helen B. Taussig and Richard J. Bing, who first described it.
Pathophysiology[edit]
In Taussig–Bing syndrome, the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle, which is the opposite of the normal anatomical configuration. This is similar to the condition known as dextro-Transposition of the great arteries (d-TGA). However, in Taussig–Bing syndrome, there is also a large ventricular septal defect that allows for mixing of oxygenated and deoxygenated blood between the ventricles. The presence of the VSD is crucial because it allows some oxygenated blood from the left ventricle to enter the aorta, which is necessary for survival. However, this mixing is inefficient, and the body receives a lower than normal amount of oxygenated blood, leading to cyanosis and other complications.
Clinical Presentation[edit]
Patients with Taussig–Bing syndrome typically present with symptoms of cyanosis shortly after birth. Other symptoms may include difficulty breathing, poor feeding, and failure to thrive. The degree of cyanosis and other symptoms can vary depending on the size of the VSD and the degree of mixing of blood.
Diagnosis[edit]
Diagnosis of Taussig–Bing syndrome is typically made using echocardiography, which can visualize the abnormal connections of the great arteries and the presence of a VSD. Additional imaging studies, such as cardiac MRI or cardiac catheterization, may be used to further assess the anatomy and plan for surgical intervention.
Treatment[edit]
The primary treatment for Taussig–Bing syndrome is surgical correction. The most common surgical approach is the arterial switch operation, which involves switching the aorta and pulmonary artery to their correct positions. This is often combined with closure of the VSD. In some cases, additional procedures may be necessary to address other associated cardiac anomalies. Postoperative care is critical, and patients require close monitoring and follow-up to manage any complications and ensure proper cardiac function.
Prognosis[edit]
With advances in surgical techniques and postoperative care, the prognosis for patients with Taussig–Bing syndrome has improved significantly. Many patients go on to lead healthy lives, although they may require ongoing cardiac care and monitoring.
Also see[edit]
- Congenital heart defect
- Transposition of the great arteries
- Ventricular septal defect
- Cyanotic heart defect
| Congenital heart diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This congenital heart disease related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian